Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab.
B
B
Moum
Z
Z
Konopski
K F
KF
Tufteland
J
J
Jahnsen
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D004798:Enzymes / Q000097:blood; D005260:Female; D006801:Humans; D000069285:Infliximab; D008099:Liver / Q000187:drug effects*; D008875:Middle Aged
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D004798:Enzymes; D000069285:Infliximab